The T-Series waste caps come in a number of bottle thread types and connect to 1/8in OD semi-rigid tubing without requiring additional fittings. The tubing pushes straight through the cap Luer ports to create a liquid- and vapour-tight seal. Other tubing sizes can be accommodated using a variety of adapters, without compromising the seal. A separate ¼in-28 UNF thread port allows connection of a vapour trap and breakthrough indicator unit.
An activated carbon vapour trap isolates any solvent fumes and prevents escape from the system during pressure venting. When the trap becomes saturated, an integrated indicator strip turns red, alerting staff to replace the trap to prevent unintentional vapour breakthrough.
The product’s design also prevents over pressurisation. As liquid is collected in the waste bottle, either under pressure or gravity feed, vapour is automatically vented to the trap to prevent explosions or injury.
Diba is based in Danbury, Connecticut, US.
Omnifit bottle cap traps harmful vapours
Integrated test strip indicates when to replace cap
You may also like
Manufacturing
Patented device reinvents Solid Phase Extraction
Read moreBiotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition
Trending Articles
You may also like
Manufacturing
Patented device reinvents Solid Phase Extraction
Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition
Manufacturing
Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility
The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's 10.6-hour half-life
Manufacturing
Catalent launches ten-month gene-to-drug substance programme for complex biologics
The accelerated pathway extends the CDMO's Rapid Antibody framework to bispecifics and next-generation formats — targeting master cell bank release by month seven and bulk drug substance lot release by month ten
Design & Build
Sterling Pharma Solutions doubles ADC manufacturing capacity at Deeside with new GMP suite
The multi-million-pound expansion adds a 1400 sqft Grade C cleanroom, OEB5 containment handling and a 3400 sqft analytical laboratory — extending Sterling's bioconjugation capability from development through to Phase III and commercial scale
Manufacturing
Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase next month
Piramal Pharma Solutions (“PPS”), a leading global Contract Development and Manufacturing Organisation (CDMO) and part of Piramal Pharma Ltd. (“PPL”) (NSE: PPLPHARMA | BSE: 543635), and its partner NP2, a nonprofit generic drug manufacturer, today announced their plans to finish the drug development phase of the generic cancer drug cyclophosphamide in October
Manufacturing
Why your coating process is less consistent than you think - and what to do about it
Tablet coating defects rarely begin at the coating stage. In this live webinar, industry expert Fred Rowley examines the upstream variables - suspension handling, spray-rate stability, gun pattern verification - that determine whether a coating process performs consistently at scale